Page last updated: 2024-10-28

glyburide and Symptom Cluster

glyburide has been researched along with Symptom Cluster in 8 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prado-Carro, AM1
Calzada-Hernández, J1
Marín, S1
Cardona-Hernandez, R1
Oriola, J1
Nicolás, M1
Ramon-Krauel, M1
Bouazza, N1
Djerada, Z1
Gozalo, C1
Busiah, K1
Beltrand, J1
Berdugo, M1
Urien, S1
Treluyer, JM1
Polak, M1
Della Manna, T1
Battistim, C1
Radonsky, V1
Savoldelli, RD1
Damiani, D1
Kok, F1
Pearson, ER1
Ellard, S2
Hattersley, AT3
Reis, AF1
Mohamadi, A1
Clark, LM1
Lipkin, PH1
Mahone, EM1
Wodka, EL1
Plotnick, LP1
Jones, AG1
Sang, Y1
Ni, G1
Gu, Y1
Liu, M1
Shimomura, K1
Hörster, F1
de Wet, H1
Flanagan, SE1
Wolf, NI1
Ashcroft, F1
Ebinger, F1
Kumar, S1
Boulton, AJ1

Trials

1 trial available for glyburide and Symptom Cluster

ArticleYear
Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:11

    Topics: Administration, Oral; Blood Glucose; Child; Child, Preschool; Cytochrome P-450 CYP2C9; Dose-Response

2016

Other Studies

7 other studies available for glyburide and Symptom Cluster

ArticleYear
Patient with iDEND syndrome-related mutation.
    Diabetes care, 2014, Volume: 37, Issue:6

    Topics: Diabetes Mellitus; Epilepsy; Female; Glyburide; Humans; Hypoglycemic Agents; Infant, Newborn; Infant

2014
Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene.
    Arquivos brasileiros de endocrinologia e metabologia, 2008, Volume: 52, Issue:8

    Topics: Brazil; Child, Preschool; Developmental Disabilities; Diabetes Mellitus; Epilepsy; Female; Glyburide

2008
Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
    Pediatric diabetes, 2010, Volume: 11, Issue:3

    Topics: Administration, Oral; Adolescent; Continuity of Patient Care; Developmental Disabilities; Diabetes M

2010
Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.
    Nature reviews. Endocrinology, 2010, Volume: 6, Issue:6

    Topics: Administration, Oral; Adolescent; Amino Acid Substitution; Developmental Disabilities; Diabetes Mell

2010
AV59M KCNJ11 gene mutation leading to intermediate DEND syndrome in a Chinese child.
    Journal of pediatric endocrinology & metabolism : JPEM, 2011, Volume: 24, Issue:9-10

    Topics: Asian People; Developmental Disabilities; Diabetes Mellitus, Type 1; Glyburide; Humans; Hypoglycemic

2011
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
    Neurology, 2007, Sep-25, Volume: 69, Issue:13

    Topics: Animals; Anticonvulsants; Cell Membrane; Child, Preschool; Developmental Disabilities; Diabetes Mell

2007
Serious, prolonged hypoglycaemia with glibenclamide in a patient with Mendenhall's syndrome.
    Clinical endocrinology, 1993, Volume: 39, Issue:1

    Topics: Abnormalities, Multiple; Adult; Diabetes Mellitus; Glyburide; Humans; Hyperplasia; Hypoglycemia; Hyp

1993